Non alcoholic
The role of Small Intestinal Bacterial Overgrowth (SIBO) in Non-alcoholic Fatty Liver Disease (NAFLD) patients evaluated using Controlled Attenuation Parameter (CAP) Transient Elastography (TE): a tertiary referral center experience
7
Progression of non alcoholic steatosis to steatohepatitis and fibrosis parallels cumulative accumulation of danger signals that promote inflammation and liver tumors in a high fat–cholesterol–sugar diet model in mice
14
Alcoholic and Non Alcoholic Marchiafava Bignami Disease: A Comparative Study
7
A non-interventional study of the genetic polymorphisms of NOD2 associated with increased mortality in non-alcoholic liver transplant patients
8
Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non-alcoholic fatty liver disease model
13
Impaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly Chinese
7
Analysis of factors influencing glucose tolerance in Japanese patients with non-alcoholic fatty liver disease
9
Hepatoprotective effects of Spirulina maxima in patients with non alcoholic fatty liver disease: a case series
5
Non-alcoholic fatty liver disease
6
Original Article Increased expression of Zinc finger protein 267 in non-alcoholic fatty liver disease
6
COMPARATIVE BIOCHEMICAL INVESTIGATION OF PATIENTS WITH ALCOHOLIC AND NON ALCOHOLIC LIVER DISEASES
16
Incidence Rate and Etiological Factors of Pancreatitis in Alcoholic and Non-alcoholic Patients
10
Cardiac Functions in Alcoholic and Non-Alcoholic Cirrhosis
85
Study of Development of Non-Alcoholic Fatty Liver Disease (NAFLD) among Type-2 Diabetes Mellitus
9
Conclusion: The prevalence of non-alcoholic fatty liver disease in type 2 diabetes mellitus was 42.6%. It
5
Assess the prevalence and compare the risk factors of Type II Diabetes Mellitus among alcoholic and non alcoholic males residing at Medavakkam, Chennai.
94
<p>A Review Of Current And Upcoming Treatment Modalities In Non-Alcoholic Fatty Liver Disease And Non-Alcoholic Steatohepatitis</p>
20
Clinical, epidemiological, and laboratory analysis of patients with non alcoholic steatohepatitis
5
Preparation of non alcoholic naturally carbonated beverage using yeast isolate from whey beverage
9
Risks and Predictors of Non-Alcoholic Liver Disease Progression Using Association Rules Mining
11